Abstract:Compound 9i, a derivative of harmine with anticancer activity, was synthesized and characterized. The results of molecular docking and molecular dynamics simulations the complex (9i and DYRK1A kinase) was compact and stable. In addition, Compound 9i may be useful as a pro‐oxidant for cancers caused by Ras over‐activation. Modifications at the harmine (HAM) 9‐N position demonstrated effective antitumor activity in previous studies. However, the difficult preparation, low yield and poor stability of derivatives limited their applications. A partial activity priming was carried out by converting the 9‐position substituted propargyl group of HAM to propynyl group. Molecular docking simulations of compound 9i with DYRK1A kinase showed that it was able to embed itself into the active pocket of the DYRK1A protein and formed hydrogen bonds with multiple active amino acid residues at a low binding energy. The results of molecular dynamics simulations showed that the RMSD (root mean square deviation) fluctuations of the complex were more gentle, and the trends of the changes in Rg (radius of gyration) and SASA (solvent accessible surface area) were lower, indicating that the DYRK1A protein was less disturbed and the structure of the complex was more compact and stable. The cytotoxicity assay indicated that compound 9i displayed good antiproliferative activity against human cancer cells MGC‐803, HepG2, and PANC‐1. In addition, 9i was able to reduce the ratio of polynomials induced by the Ras overexpression model of Caenorhabditis elegans, which showed anti‐Ras activity, and the RT‐qPCR results suggested that its anti‐Ras ability was not achieved by directly inhibiting the expression of the let‐60/Ras genes, and that 9i was able to upregulate the expression of SOD‐3 activation of oxidative stress, which means that it may be useful as a pro‐oxidant for the treatment of cancers caused by Ras over‐activation.

DNA binding properties of 9-substituted harmine derivatives.

Synthesis and Biological Evaluation of 1,2,7,9-Tetrasubstituted Harmine Derivatives As Potential Antitumor Agents

Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.

Design of Β-Carboline Derivatives As DNA-targeting Antitumor Agents

Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives

Synthesis and Structure–activity Relationships of Harmine Derivatives As Potential Antitumor Agents

Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.

ChemInform Abstract: Synthesis and Biological Evaluation of 1,9‐disubstituted Β‐carbolines As Potent DNA Intercalating and Cytotoxic Agents.

Design, Synthesis, and Biological Evaluation of Harmine Derivatives As Topoisomerase I Inhibitors for Cancer Treatment

Synthesis, cytotoxic activities and DNA binding properties of β-carboline derivatives.

Synthesis And Biological Evaluation Of Novel Beta-Carbolines As Potent Cytotoxic And Dna Intercalating Agents

Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents

Synthesis and Antiproliferative Activity of 9-Benzylamino-6-chloro-2-methoxy-acridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors.

Synthesis and in Vitro Cytotoxic Evaluation of Novel 3,4, 5-Trimethoxyphenyl Substituted Beta-Carboline Derivatives

Novel Harmine Derivatives for Tumor Targeted Therapy

Intercalation, Cytotoxicity, and Molecular Modeling of Acenaphtho[1,2-b]pyrrole Chromophores As a New Family of Antitumor Agents

CC-1065 analogues bearing different DNA-binding subunits: synthesis, antitumor activity, and preliminary toxicity study.

Design, antitumor, and anti‐Ras activity of propynyl‐substituted harmine bases

Synthesis and Antitumor Activity of N9 Position Aromatic Substituted Purine-8-one Derivatives

Oxoaporphine alkaloid derivatives:DNA binding affinity and cytotoxicity

Novel Synthetic 2-Amino-10-(3,5-dimethoxy)benzyl-9(10h)-acridinone Derivatives As Potent DNA-binding Antiproliferative Agents.